Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of androgen-dependent Nb rat prostate adenocarcinoma

J. R. Drago, L. B. Goldman, R. E. Maurer, D. D. Eckels, M. Eric Gershwin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

For 17 months, Noble (Nb) rat prostate adenocarcinomas were evaluated in various experimental and therapeutic groups. Histologic evaluation of these tumors revealed them to be stable throughout more than 40 tumor transplant generations. The tumor growth pattern in unmanipulated Nb rats was also stable during that time, with less than 10% variation. The acid phosphatase content was determined with the use of the thymolphthalein method, which revealed production of acid phosphatase by these tumors. In addition in approximately 22% of all Nb rat prostate tumors developed pulmonary metastases. The autonomous tumors resulted in a much higher rate of metastases than did the hormonally dependent tumors: 35% versus 18%, respectively. Histochemical staining revealed acid phosphatase in the normal dorsolateral lobe of the Nb rat prostate gland and also in the prostate tumors. The reaction was more positive in the androgen-dependent tumors than in the autonomous ones. One androgen-dependent tumor, which mimics the humoral response of human prostate carcinoma, was chosen to evaluate treatment modalities, castration and chemotherapy (1,3 bis(2-chloroethyl)-1-nitrosourea, adriamycin, and methotrexate). Results were significant with all modalities (P<0.001); however, chemotherapy was more efficacious than was castration in reducing tumor growth. These parameters helped to establish the Nb rat prostate adenocarcinoma model as appropriate for enhancing knowledge of human tumor biology and response to therapy.

Original languageEnglish (US)
Pages (from-to)931-937
Number of pages7
JournalJournal of the National Cancer Institute
Volume64
Issue number4
StatePublished - 1980
Externally publishedYes

Fingerprint

Androgens
Prostate
Histology
Adenocarcinoma
Neoplasms
Therapeutics
Acid Phosphatase
Castration
Thymolphthalein
prostatic acid phosphatase
Neoplasm Metastasis
Drug Therapy
Carmustine
Growth
Methotrexate
Doxorubicin
Staining and Labeling
Carcinoma
Transplants
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of androgen-dependent Nb rat prostate adenocarcinoma. / Drago, J. R.; Goldman, L. B.; Maurer, R. E.; Eckels, D. D.; Gershwin, M. Eric.

In: Journal of the National Cancer Institute, Vol. 64, No. 4, 1980, p. 931-937.

Research output: Contribution to journalArticle

@article{f355e3d38352428781f2f70e80627d2a,
title = "Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of androgen-dependent Nb rat prostate adenocarcinoma",
abstract = "For 17 months, Noble (Nb) rat prostate adenocarcinomas were evaluated in various experimental and therapeutic groups. Histologic evaluation of these tumors revealed them to be stable throughout more than 40 tumor transplant generations. The tumor growth pattern in unmanipulated Nb rats was also stable during that time, with less than 10{\%} variation. The acid phosphatase content was determined with the use of the thymolphthalein method, which revealed production of acid phosphatase by these tumors. In addition in approximately 22{\%} of all Nb rat prostate tumors developed pulmonary metastases. The autonomous tumors resulted in a much higher rate of metastases than did the hormonally dependent tumors: 35{\%} versus 18{\%}, respectively. Histochemical staining revealed acid phosphatase in the normal dorsolateral lobe of the Nb rat prostate gland and also in the prostate tumors. The reaction was more positive in the androgen-dependent tumors than in the autonomous ones. One androgen-dependent tumor, which mimics the humoral response of human prostate carcinoma, was chosen to evaluate treatment modalities, castration and chemotherapy (1,3 bis(2-chloroethyl)-1-nitrosourea, adriamycin, and methotrexate). Results were significant with all modalities (P<0.001); however, chemotherapy was more efficacious than was castration in reducing tumor growth. These parameters helped to establish the Nb rat prostate adenocarcinoma model as appropriate for enhancing knowledge of human tumor biology and response to therapy.",
author = "Drago, {J. R.} and Goldman, {L. B.} and Maurer, {R. E.} and Eckels, {D. D.} and Gershwin, {M. Eric}",
year = "1980",
language = "English (US)",
volume = "64",
pages = "931--937",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of androgen-dependent Nb rat prostate adenocarcinoma

AU - Drago, J. R.

AU - Goldman, L. B.

AU - Maurer, R. E.

AU - Eckels, D. D.

AU - Gershwin, M. Eric

PY - 1980

Y1 - 1980

N2 - For 17 months, Noble (Nb) rat prostate adenocarcinomas were evaluated in various experimental and therapeutic groups. Histologic evaluation of these tumors revealed them to be stable throughout more than 40 tumor transplant generations. The tumor growth pattern in unmanipulated Nb rats was also stable during that time, with less than 10% variation. The acid phosphatase content was determined with the use of the thymolphthalein method, which revealed production of acid phosphatase by these tumors. In addition in approximately 22% of all Nb rat prostate tumors developed pulmonary metastases. The autonomous tumors resulted in a much higher rate of metastases than did the hormonally dependent tumors: 35% versus 18%, respectively. Histochemical staining revealed acid phosphatase in the normal dorsolateral lobe of the Nb rat prostate gland and also in the prostate tumors. The reaction was more positive in the androgen-dependent tumors than in the autonomous ones. One androgen-dependent tumor, which mimics the humoral response of human prostate carcinoma, was chosen to evaluate treatment modalities, castration and chemotherapy (1,3 bis(2-chloroethyl)-1-nitrosourea, adriamycin, and methotrexate). Results were significant with all modalities (P<0.001); however, chemotherapy was more efficacious than was castration in reducing tumor growth. These parameters helped to establish the Nb rat prostate adenocarcinoma model as appropriate for enhancing knowledge of human tumor biology and response to therapy.

AB - For 17 months, Noble (Nb) rat prostate adenocarcinomas were evaluated in various experimental and therapeutic groups. Histologic evaluation of these tumors revealed them to be stable throughout more than 40 tumor transplant generations. The tumor growth pattern in unmanipulated Nb rats was also stable during that time, with less than 10% variation. The acid phosphatase content was determined with the use of the thymolphthalein method, which revealed production of acid phosphatase by these tumors. In addition in approximately 22% of all Nb rat prostate tumors developed pulmonary metastases. The autonomous tumors resulted in a much higher rate of metastases than did the hormonally dependent tumors: 35% versus 18%, respectively. Histochemical staining revealed acid phosphatase in the normal dorsolateral lobe of the Nb rat prostate gland and also in the prostate tumors. The reaction was more positive in the androgen-dependent tumors than in the autonomous ones. One androgen-dependent tumor, which mimics the humoral response of human prostate carcinoma, was chosen to evaluate treatment modalities, castration and chemotherapy (1,3 bis(2-chloroethyl)-1-nitrosourea, adriamycin, and methotrexate). Results were significant with all modalities (P<0.001); however, chemotherapy was more efficacious than was castration in reducing tumor growth. These parameters helped to establish the Nb rat prostate adenocarcinoma model as appropriate for enhancing knowledge of human tumor biology and response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0018841553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018841553&partnerID=8YFLogxK

M3 - Article

C2 - 6929004

AN - SCOPUS:0018841553

VL - 64

SP - 931

EP - 937

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 4

ER -